Database

Startups

Main Industry
Health Care
Main Product/Service
A speech biomarker–based digital platform for early cognitive screening and non-pharmaceutical stimulation in dementia prevention.
Founded Year
2024
Unified Business No.
00131702
Status
Active
Number of Employees
0
Total Paid-in Capital
2,050,000 (NT$)
Location of Company
Taiwan , Taoyuan City
Year of establishment, company status, responsible person, paid-in capital amount, and registered address are sourced from the "Commerce Industrial Services Portal, Department of Commerce, MOE. Exit status refers to various situations, including emerging stock exchanges (e.g., potential exits), mergers and acquisitions (M&A), and IPOs. The overseas development countries are collected through information provided by startups themselves and the information filled in when registering for matchmaking events. Therefore, the information cannot be updated in real time. If you wish to make corrections, please email findit.tier@gmail.com. Thank you. Notice: This data is compiled from public sources for reference only. We have no direct affiliation with the company and are not their contact person. Please do not contact this platform for company inquiries.
About the Company
KVQ Intelligence focuses on voice AI. Its product, AI-Brain Quick Screening, uses vocal biomarkers to provide a non-invasive, high-accuracy cognitive screening tool. It can be used for early dementia detection as well as non-pharmacological cognitive stimulation therapy for people with dementia. AI-Brain is the first tool on LINE for cognitive screening, the first platform to predict both CASI and MMSE scores using voice, and the fastest cognitive screening tool in the world. The web version offers predictions of seven cognitive domain scores and provides a management system for easily tracking test subject’s historical test results.



More ↓

Similar Companies

Singular Wings Medical Co., Ltd.

Our system is specifically designed to support medical institutions in managing chronic conditions such as cardiovascular diseases (e.g., arrhythmia), obstructive sleep apnea (OSA), and the forthcoming non-invasive continuous glucose monitoring system (CG

mProbe Taiwan Inc.

mProbe is aiding oncologists in making informed clinical decisions by providing more comprehensive tumor profiling. And we can deliver more information with less tissue and in less time. With just 2 slides, our patented process allows us to identify over